NCT05575154

Brief Summary

This study sought to determine the percentage of normal eyes that followed the ISNT rule by retinal nerve fiber layer (RNFL) and neuroretinal rim thickness measurements using optical coherence tomography (OCT) , and secondarily, whether alternative rules may be more applicable or easily generalized.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
116

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Dec 2022

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 9, 2021

Completed
1 year until next milestone

First Posted

Study publicly available on registry

October 12, 2022

Completed
2 months until next milestone

Study Start

First participant enrolled

December 1, 2022

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2023

Completed
Last Updated

October 12, 2022

Status Verified

October 1, 2022

Enrollment Period

1.1 years

First QC Date

October 9, 2021

Last Update Submit

October 8, 2022

Conditions

Keywords

ISNT rule in normal population

Outcome Measures

Primary Outcomes (1)

  • ISNT rule prevalence in normal population

    the percentage of normal eyes that followed the ISNT rule by retinal nerve fiber layer and neuroretinal rim thickness measurements using (OCT)

    Baseline

Secondary Outcomes (1)

  • variants of ISNT rule

    Baseline

Interventions

measuring retinal nerve fiber layer and neuroretinal rim thickness

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Normal population

You may qualify if:

  • a normal eye examination without ocular diseases except for cataracts
  • best corrected vision of \> 6/12
  • a normal VF test result defined by a pattern standard deviation value of \> 5% compared to age matched controls in the perimeter's normative database and a glaucoma hemifield test within normal limits
  • a spherical equivalent of between -5 and +5 diopters.

You may not qualify if:

  • unreliable VF testing with \> 33% fixation losses, \> 20% false positives, or \> 20% false negatives.
  • any history of ocular hypertension or intraocular pressures \> 21mmHg at the time of the visit;
  • inter-eye cup-to-disc ratio (CDR) asymmetry of \> 0.2;CDR of \> 0.4
  • history of a neurologic disease or systemic medication that could produce VF defects.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (18)

  • Foster PJ, Buhrmann R, Quigley HA, Johnson GJ. The definition and classification of glaucoma in prevalence surveys. Br J Ophthalmol. 2002 Feb;86(2):238-42. doi: 10.1136/bjo.86.2.238.

    PMID: 11815354BACKGROUND
  • Quigley HA. Glaucoma. Lancet. 2011 Apr 16;377(9774):1367-77. doi: 10.1016/S0140-6736(10)61423-7. Epub 2011 Mar 30.

    PMID: 21453963BACKGROUND
  • Bourne RR, Taylor HR, Flaxman SR, Keeffe J, Leasher J, Naidoo K, Pesudovs K, White RA, Wong TY, Resnikoff S, Jonas JB; Vision Loss Expert Group of the Global Burden of Disease Study. Number of People Blind or Visually Impaired by Glaucoma Worldwide and in World Regions 1990 - 2010: A Meta-Analysis. PLoS One. 2016 Oct 20;11(10):e0162229. doi: 10.1371/journal.pone.0162229. eCollection 2016.

    PMID: 27764086BACKGROUND
  • Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014 Nov;121(11):2081-90. doi: 10.1016/j.ophtha.2014.05.013. Epub 2014 Jun 26.

    PMID: 24974815BACKGROUND
  • Keltner JL, Johnson CA, Anderson DR, Levine RA, Fan J, Cello KE, Quigley HA, Budenz DL, Parrish RK, Kass MA, Gordon MO; Ocular Hypertension Treatment Study Group. The association between glaucomatous visual fields and optic nerve head features in the Ocular Hypertension Treatment Study. Ophthalmology. 2006 Sep;113(9):1603-12. doi: 10.1016/j.ophtha.2006.05.061.

    PMID: 16949445BACKGROUND
  • Broadway DC, Nicolela MT, Drance SM. Optic disk appearances in primary open-angle glaucoma. Surv Ophthalmol. 1999 Jun;43 Suppl 1:S223-43. doi: 10.1016/s0039-6257(99)00007-7.

    PMID: 10416767BACKGROUND
  • Jonas JB, Budde WM. Diagnosis and pathogenesis of glaucomatous optic neuropathy: morphological aspects. Prog Retin Eye Res. 2000 Jan;19(1):1-40. doi: 10.1016/s1350-9462(99)00002-6.

    PMID: 10614679BACKGROUND
  • Jonas JB, Gusek GC, Naumann GO. Optic disc, cup and neuroretinal rim size, configuration and correlations in normal eyes. Invest Ophthalmol Vis Sci. 1988 Jul;29(7):1151-8.

    PMID: 3417404BACKGROUND
  • Jonas JB, Budde WM, Panda-Jonas S. Ophthalmoscopic evaluation of the optic nerve head. Surv Ophthalmol. 1999 Jan-Feb;43(4):293-320. doi: 10.1016/s0039-6257(98)00049-6.

    PMID: 10025513BACKGROUND
  • Varma R, Skaf M, Barron E. Retinal nerve fiber layer thickness in normal human eyes. Ophthalmology. 1996 Dec;103(12):2114-9. doi: 10.1016/s0161-6420(96)30381-3.

    PMID: 9003346BACKGROUND
  • Dichtl A, Jonas JB, Naumann GO. Retinal nerve fiber layer thickness in human eyes. Graefes Arch Clin Exp Ophthalmol. 1999 Jun;237(6):474-9. doi: 10.1007/s004170050264.

    PMID: 10379607BACKGROUND
  • Jonas JB, Budde WM, Lang P. Neuroretinal rim width ratios in morphological glaucoma diagnosis. Br J Ophthalmol. 1998 Dec;82(12):1366-71. doi: 10.1136/bjo.82.12.1366.

    PMID: 9930265BACKGROUND
  • Harizman N, Oliveira C, Chiang A, Tello C, Marmor M, Ritch R, Liebmann JM. The ISNT rule and differentiation of normal from glaucomatous eyes. Arch Ophthalmol. 2006 Nov;124(11):1579-83. doi: 10.1001/archopht.124.11.1579.

    PMID: 17102005BACKGROUND
  • Law SK, Kornmann HL, Nilforushan N, Moghimi S, Caprioli J. Evaluation of the "IS" Rule to Differentiate Glaucomatous Eyes From Normal. J Glaucoma. 2016 Jan;25(1):27-32. doi: 10.1097/IJG.0000000000000072.

    PMID: 24844540BACKGROUND
  • Morgan JE, Bourtsoukli I, Rajkumar KN, Ansari E, Cunliffe IA, North RV, Wild JM. The accuracy of the inferior>superior>nasal>temporal neuroretinal rim area rule for diagnosing glaucomatous optic disc damage. Ophthalmology. 2012 Apr;119(4):723-30. doi: 10.1016/j.ophtha.2011.10.004. Epub 2012 Feb 24.

    PMID: 22365059BACKGROUND
  • Dave P, Shah J. Applicability of ISNT and IST rules to the retinal nerve fibre layer using spectral domain optical coherence tomography in early glaucoma. Br J Ophthalmol. 2015 Dec;99(12):1713-7. doi: 10.1136/bjophthalmol-2014-306331. Epub 2015 May 28.

    PMID: 26021327BACKGROUND
  • Pradhan ZS, Braganza A, Abraham LM. Does the ISNT Rule Apply to the Retinal Nerve Fiber Layer? J Glaucoma. 2016 Jan;25(1):e1-4. doi: 10.1097/IJG.0000000000000064.

    PMID: 24777047BACKGROUND
  • Sihota R, Srinivasan G, Dada T, Gupta V, Ghate D, Sharma A. Is the ISNT rule violated in early primary open-angle glaucoma--a scanning laser tomography study. Eye (Lond). 2008 Jun;22(6):819-24. doi: 10.1038/sj.eye.6702798. Epub 2007 Apr 13.

    PMID: 17435693BACKGROUND

MeSH Terms

Conditions

Glaucoma

Interventions

Tomography, Optical Coherence

Condition Hierarchy (Ancestors)

Ocular HypertensionEye Diseases

Intervention Hierarchy (Ancestors)

Tomography, OpticalOptical ImagingDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisTomographyInvestigative Techniques

Study Officials

  • Abd-Elnasser A Mohamed, PhD

    Assiut University

    STUDY DIRECTOR

Central Study Contacts

Amr M Sayed, M.B.B.Ch.

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Resident ophthalmologist

Study Record Dates

First Submitted

October 9, 2021

First Posted

October 12, 2022

Study Start

December 1, 2022

Primary Completion

December 30, 2023

Study Completion

December 30, 2023

Last Updated

October 12, 2022

Record last verified: 2022-10